Background Testicular cancer is the commonest malignancy in young men. Improvements in survival rates have led to campaigns to raise awareness in at-risk men. We assessed the changing size of testicular tumours given the public health initiatives promoting testicular selfexamination (TSE).
Introduction
In the UK, testicular cancer is uncommon, accounting for only 1% of new cancer diagnoses but is the commonest cancer in young males (,40 years of age). 1 In the last 40 years, the incidence has doubled in the UK, but survival rates have increased by 40% in the same period. 2 With men less likely to recognize health problems or seek professional help, 3 twinned with the improved testicular cancer survival rates, public health drives have attempted to raise awareness of this disease.
We aimed to evaluate whether increasing awareness of testicular cancer, following or during multiple public health promotions, affected the size of testicular tumours at presentation among varying age groups. Data collected between 1975 and 1985 was compared with data from 2007 to 2014, looking mainly at size of tumour at presentation.
Methods
Patients were identified using the Merseyside and Cheshire Cancer Registry, a prospective regional database of new cancer diagnoses. Those undergoing orchidectomy at our institution from 1975 to 85 and 2007 to 12 were used as an old and new cohort, respectively. Combination of computerized (ICE desktop TM , Sunquest Systems, Tucson, AZ, USA) and paper patient records identified age at presentation and histopathological data which were used to ascertain histology and tumour size. For analysis purposes, age at presentation was separated into four groups: 16-29, 30-44, 45-59 and .60 years to reflect the peak incidence of non-seminomas (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) , seminomas (30-44) and lymphomas (.50). Tumour size was represented as the maximum measured dimension of the gross specimen.
Statistical analysis was performed using Fisher's exact test and Student's t-test for parametric and Mann -Whitney U test for non-parametric data. Analyses were carried out using StatsDirect TM (Stats Direct Ltd, Altrincham, UK). Statistical significance was indicated by P , 0.05.
Results
A total of 305 orchidectomies were performed for germ cell tumours between 1975 -85 and 2007 -12, and sizes were available for 215 of these. One hundred and thirty-three were performed from 1975 to 1985 and 82 from 2007 to 2012. The median age of presentation was 34 years (range 16-75). Histologically, 57% of tumours were seminomas with 43% being non-seminomas. There was no difference in the proportion of these tumours between time periods. Overall, tumour size was significantly larger among those presenting over 60 years of age compared with younger patients (80 versus 53 mm, P , 0.05).
In the 2007 -12 group, a higher proportion of patients presented at a younger age compared with the 1975 -85 group with the biggest change seen in the 15-29 year age range (42.5 versus 29%; P ¼ 0.02). Subsequently, there was a decrease in proportion of patients presenting in the older age group (4 versus 15%) ( Table 1) .
Tumour size showed a significant decrease in the two periods with a mean tumour size of 72 mm from 1975 to 1985 and 41 mm from 2007 to 2012 (P ¼ 0.02). The mean tumour size by year is illustrated in Fig. 1 . This reduction is seen in all age groups, but the greatest difference is seen in those between 45 and 59 years showing a 52% reduction (P , 0.001). There was a non-significant reduction in the tumour size in the .60 years age group (18%, P ¼ 0.07) ( Table 2 ) despite this group presenting with larger tumour sizes.
Discussion
Main finding of this study Over the last 40 years despite an increasing incidence of testicular cancer, 5-year survival rates have risen from 69 to 95%. 4 The use of platinum-based chemotherapy for advanced disease has been the main factor in this improvement. 5, 6 Improved survival rates have driven awareness with patient education on testicular cancer and self-examination also increasing. 7 Our observations showed a significant decrease in testicular tumour size in the last 40 years from 7.2 to 4.1 cm.
We also observed that a greater proportion of patients were presenting in the younger age group (42.5 versus 29%) in the more recent period. Worldwide trends indicate an increasing incidence in testicular cancer, 8 and within the UK, this increase has been more pronounced in the younger age groups particularly 30-44 years of age. 4 Patients under 60 years of age also showed a greater overall reduction in tumour size over time. Conversely, although they had the largest tumour size at presentation, the over 60s age group exhibited the smallest reduction in tumour size between the two time periods.
During the late 1980s and earlier 1990s, several studies explored methods to promote awareness of testicular cancer and the validity of interventions promoting testicular selfexamination in the at-risk age groups.
9 -11 This coincided with an increase in public health and charity initiatives in the UK to educate young men about testicular cancer. In 1994, the department of health set up and funded the Men's Health Forum which aimed to promote men's health issues and shift attitudes that often led to men ignoring signs of ill-health. Their produced clothing products to further raise awareness with slogans such as 'Bollocks to cancer' and 'I love my balls' as well as underwear with printed instructions on how to perform TSE. As awareness increased, a variety of charitable organizations were set up to specifically target testicular cancer and self-awareness. Orchid, the earliest UK charity set up in 1996, published online self-help videos entitled 'Know Your Balls: check 'em out' while Everyman's 'Notice your nuts' campaign involved celebrity endorsed TV advertisements to encourage TSE. These charities often use voluntary 'education teams' who visit schools and colleges to promote and empower the male teenage population. Undoubtedly, one of the highest profile celebrities who would become synonymous with testicular cancer was professional cyclist Lance Armstrong who set up his Livestrong foundation in 1997 to fund research and self-awareness following his own battle with testicular cancer.
As the profile of testicular cancer rose, more celebrities highlighted their own stories and now the internet is awash with online self-help forums and regional charities with the aim to further increase education at a local level.
This explosion of recognition of testicular cancer in the younger generations occurred between our two cohorts and may offer an explanation to our findings. However, as others have discovered, although these campaigns and initiatives are aimed predominantly at men, women appear to have an equal recognition of testicular cancer and the importance of TSE and may play an important role promoting health behaviours in men. 12 It is not just testicular cancer patients but relatives and partners who are also affected by the disease; 13 with increasing incidence and survival, more of these experiences are likely to be shared among peers and friends which may also drive the purported awareness. Between our two time periods, there has also been a change in the education standards within the UK with higher achievement of GCSEs, A levels and university degrees.
14 The higher intellectual aptitude of the at-risk population may have contributed to an increased mindfulness and empowerment to seek medical attention at an earlier stage.
What is already known on this topic?
Other results support the findings found here. Bhardwa et al. 15 analysed testicular tumour size in London from 1984 to 2003 and found a decrease from 4 to 2.5 cm. In Japan, Kobayashi et al. 16 found a more moderate decrease in tumour size (6.7-5.8 cm) from 1991 to 2010, although this was not their primary end point. It has been suggested that increasing awareness among young men has reduced the duration of symptoms at first presentation. 17 Kobyashi et al. 16 also showed that during the time period of their study there was a reduction in symptom duration prior to seeking medical attention which correlated with the reduction in tumour size. In the UK, a reduction was also seen in the duration of symptoms at presentation to General Practice in 2002 compared with 1985.
18
A 20-year European study showed a slight decrease in diagnostic delay but not to a significant extent. 19 What this study adds?
The younger distribution of patients presenting with testicular cancer and the reduction in tumour size following orchidectomy suggest a generational shift with increasing awareness among younger men. Reduction in tumour size may suggest more rigorous self-examination, but other studies have highlighted the reduced time in seeking medical attention both of which indicate a heightened self-awareness. The work of charity organizations and celebrity sufferers has gone some way to raising awareness.
While others have established the decrease in size over the last two decades, we showed that a similar trend exists over the last four decades. This is of particular importance given the discovery of platinum-based chemotherapy agents in the 1970s which radically improved testicular cancer survival. Our study also explores the size reduction in tumour by age at presentation which to our knowledge is the first to address this question. We found a larger proportion of younger patients presenting with testicular cancer in more recent years but also these patients showed a tumour size reduction that was not seen in the eldest age group. It would appear that the initiatives outlined above, which occurred between our two cohorts, seem to be successful at raising awareness in the age groups most at risk. Although most age groups showed a significant reduction in tumour size, this was not replicated in the over 60 group. This group did present with the largest tumour size in both cohorts and were the only age group not to exhibit a significant reduction. Incidence within this age group is low accounting for 6.1% of all new testicular cancer cases in 2012; however, over 60s account for 23% of all testicular cancer deaths highlighting the importance of not neglecting this group in awareness campaigns. 20 Diagnostic delay does result in worse survival particular in non-seminomas where 4-year survival is 95% if symptoms ,3 months, but 65% if symptoms .6 months. 19 Earlier detection in other cancers is associated with improved mortality in this age group. 21 Although awareness among the at-risk age groups has increased over the last 20 years, 7 there has been concern that due to the relative rarity of testicular cancer, increased awareness, and in particular self-examination, can lead to undue worry. 22, 23 These concerns have led to TSE being downgraded by the United States Preventive Services Task Force to a Grade D level defined as 'moderate or high certainty that the service has no net benefit or that the harms outweigh the benefits'. 24 However, increased delay in seeking medical attention and increased tumour size do have a negative survival effect in particular for non-seminomatous disease, 16, 19 and there does appear to be cost benefit in preventing advanced stage disease. 25 It is also worth noting that public perception for testicular cancer education is viewed positively while the potential to cause undue worry is not considered a disincentive to promoting awareness. 26 These views are important, but the issue of the 'worried well' should be an essential consideration when devising and delivering awareness initiatives. A focus on the benign conditions that form the majority of palpable intrascrotal lesions should be a compulsory element of education programs. In particular, self-examination videos might benefit from explanation and demonstration that extratesticular lumps are predominantly benign.
Limitations of this study
Our study was a retrospective analysis which impedes its robustness. Unfortunately, data on metastatic disease and survival were not available for our older cohort precluding such analysis. However, size at presentation has been shown to correlate with metastatic disease. 15 
Conclusion
Despite the increasing incidence of testicular cancer, there has been a reduction in tumour size at presentation as evidenced here and by others. There are also an increased proportion of younger patients presenting suggesting a generational shift in attitudes to men's health. One concern may be that public health drives are all aimed at the younger males. We must continue to raise awareness and the importance of self-exam not only for the young but also for older men.
